Investment Firm Vents $100 Million into Injective, Securing First Publicly-Traded INJ Status

In a significant move that aligns traditional finance with blockchain-based liquidity rails, Pineapple Financial has announced the creation of a $100 million Injective digital asset treasury. The treasury, which will accumulate Injective's native token, INJ, over the coming months, has garnered the support of several institutional backers, including FalconX, Monarq, Abraxas, Kraken, Blockchain.com, Canary Capital, D. Boral Capital, and the Injective Foundation.

The Injective Foundation was among the investors in the placement, demonstrating a growing interest in the Injective network. The treasury's creation has attracted attention across both traditional finance and crypto circles, marking a first for Wall Street as Pineapple Financial becomes the first publicly listed company to hold INJ at scale.

The Injective blockchain, known for its emphasis on low fees and institutional readiness, was selected by Pineapple Financial for its treasury asset. The move is expected to help reshape functions in banking, lending, and securitization with faster settlement and greater transparency.

The treasury's goal is to generate consistent returns while holding a liquid asset tied to blockchain finance. The expected annual staking yield of roughly 12 percent adds another layer to Pineapple Financial's strategy. Injective's token, INJ, offers competitive staking yields compared to other blockchain networks, making it an attractive choice for long-term token exposure and a steady yield.

Usage of the Injective blockchain has risen sharply this year, with activity climbing over 1,000 percent since January. The network has handled over $60 billion in transactions, reflecting its growing popularity and potential.

Pineapple Financial plans to continue exploring opportunities at the intersection of finance and blockchain, seeing Injective as a key enabler of future liquidity rails for markets worldwide. The treasury's expansion will occur over the coming months as Pineapple deploys the full capital into INJ accumulation.

This is the first time Wall Street has formally held Injective, and the move is expected to further solidify the blockchain's position in the financial sector. The treasury's goal of generating consistent returns while holding a liquid asset tied to blockchain finance could pave the way for more traditional financial institutions to adopt blockchain technology.

The placement was backed by additional investors, including D. Boral Capital, Monarq, Abraxas, and the Injective Foundation, further demonstrating the wide-spread support for the Injective network and its potential to revolutionize the financial industry.

Investment Firm Vents $100 Million into Injective, Securing First Publicly-Traded INJ Status